Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

MetricPFEPfizerBMYBristol Myers SquibbMRKMerck & Co.
Snapshot
Price$25.08$54.70$115.48
Market cap$143.68B$110.27B$281.24B
Valuation
P/E19.1x18.5x31.4x
Forward P/E20.2x14.6x44.8x
Growth
Revenue growth1.4%1.8%2.9%
EPS growth-5.3%26.3%-48.3%
Profitability
Net margin11.8%12.3%13.6%
ROE8.4%41.6%17.9%
Balance sheet & cash
Debt / equity0.75x2.44x0.94x
Free cash flow yield11.2%15.4%2.9%
Dividend yield6.6%4.5%3.0%
Verdict
Investment ratingNeutral· 48Favorable· 60Weak· 40

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearPFEtoday $25BMYtoday $55MRKtoday $115
2027$19.19 – $28.14+12% CAGR$51.80 – $75.98+39% CAGR$88.34 – $129.57+12% CAGR
2028$19.57 – $28.70+7% CAGR$65.41 – $95.94+32% CAGR$90.11 – $132.16+7% CAGR
2029$19.96 – $29.28+5% CAGR$82.59 – $121.14+30% CAGR$91.91 – $134.80+5% CAGR
2030$20.36 – $29.86+4% CAGR$104.29 – $152.96+29% CAGR$93.75 – $137.50+4% CAGR
2031$20.77 – $30.46+4% CAGR$131.69 – $193.14+29% CAGR$95.62 – $140.25+4% CAGR
5-yr CAGR-3.7% – 4.0%19.2% – 28.7%-3.7% – 4.0%